The expression of p63 during epidermal remodeling in psoriasis

Journal of Dermatology

Volumn 32, Issue 4, 2005, Pages 236-242

  Shen, Chun Shen ^a,b   Tsuda, Tatsuya ^b,c   Fushiki, Shinji ^a   Mizutani, Hitoshi ^c   Yamanishi, Kiyofumi ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Epidermis; p63; Psoriasis; Remodeling; Transcription factor

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P63;

ARTICLE; BASAL CELL; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPIDERMIS; EPIDERMIS HYPERPLASIA; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KERATINIZATION; KERATINOCYTE; PROTEIN EXPRESSION; PSORIASIS; STEM CELL;

EID: 19744376017     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00755.x     Document Type: Article

References (25)

1. Weinstein GD, McCullough JL, Ross PA: Cell kinetic basis for pathophysiology of psoriasis, J Invest Dermatol, 85: 579-583, 1985.
2. Iizuka H, Takahashi H, Ishida-Yamamoto A: Psoriatic architecture constructed by epidermal remodeling, J Dermatol Sci, 35: 93-99, 2004.
3. Cook PW, Pittelkow MR, Keeble WW, Graves-Deal R, Coffey RJ Jr, Shipley GD: Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas, Cancer Res, 52: 3224-3227, 1992.
4. Sergi C, Kahl P, Otto HF: Immunohistochemical localization of transforming growth factor-alpha and epithelial growth factor receptor in human fetal developing skin, psoriasis and restrictive dermopathy, Pathol Oncol Res, 6: 250-255, 2000.
5. Krueger JG: The immunologic basis for the treatment of psoriasis with new biologic agents, J Am Acad Dermatol, 46: 1-23, 2002.
6. Nickoloff BJ, Nestle FO: Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities, J Clin Invest, 113: 1664-1675, 2004.
7. van Bokhoven H, McKeon F: Mutations in the p53 homolog p63: Allele-specific developmental syndromes in humans, Trends Mol Med, 8: 133-139, 2002.
8. Mills AA, Zheng B, Wang XJ, et al: p63 is a p53 homologue required for limb and epidermal morphogenesis, Nature, 398: 708-713, 1999.
9. Pellegrini G, Dellambra E, Golisano O, et al: p63 identifies keratinocyte stem cells, Proc Natl Acad Sci U S A, 98: 3156-3161, 2001.
10. Bamberger C, Schmale H: Identification and tissue distribution of novel KET/p63 splice variants, FEBS Lett, 501: 121-126, 2001.
11. Bamberger C, Pollet D, Schmale H: Retinoic acid inhibits downregulation of Np63 expression during terminal differentiation of human primary keratinocytes, J Invest Dermatol, 118: 133-138, 2002.
12. Yang A, Kaghad M, Wang Y, et al: p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities, Mol Cell, 2: 305-316, 1998.
13. King KE, Ponnamperuma RM, Yamashita T, et al: DeltaNp63alpha functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes, Oncogene, 5: 3635-3644, 2003.
14. Koster MI, Kim S, Mills AA, DeMayo FJ, Roop DR: p63 is the molecular switch for initiation of an epithelial stratification program, Genes Dev, 18: 126-131, 2004.
15. Reis-Filho JS, Torio B, Albergaria A, Schmitt FC: p63 expression in normal skin and usual cutaneous carcinomas, J Cutan Pathol, 29: 517-523, 2002.
16. Parsa R, Yang A, McKeon F, Green H: Association of p63 with proliferative potential in normal and neoplastic human keratinocytes, J Invest Dermatol, 113: 1099-1105, 1999.
17. Tsujita-Kyutoku M, Kiuchi K, Danbara N, et al: p63 expression in normal human epidermis and epidermal appendages and their tumors, J Cutan Pathol, 30: 11-17, 2003.
18. Wu G, Nomoto S, Hoque MO, et al: DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development, Cancer Res, 63: 2351-2357, 2003.
19. Meyerson M, Enders GH, Wu CL, et al: A family of human cdc2-related protein kinases, EMBO J, 11: 2909-2917, 1992.
20. Okuda T, Valentine VA, Shapiro DN, Downing JR: Cloning of genomic loci and chromosomal localization of the human PCTAIRE-1 and -3 protein kinase genes, Genomics, 21: 217-221, 1994.
21. Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD: Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis, J Exp Med, 178: 1271-1281, 1993.
22. Marchbank A, Su LJ, Walsh P, et al: The CUSP DeltaNp63alpha isoform of human p63 is down-regulated by solar-simulated ultraviolet radiation, J Dermatol Sci, 32: 71-74, 2003.
23. Liefer KM, Koster MI, Wang XJ, et al: Down-regulation of p63 is required for epidermal UV-B-induced apoptosis, Cancer Res, 60: 4016-4020, 2000.
24. Detmar M, Brown LF, Claffey KP, et al: Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis, J Exp Med, 180: 1141-1146, 1994.
25. Schroder JM, Christophers E: Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales, J Invest Dermatol, 87: 53-58, 1986.